Peter C. M. McWilliams

Directeur Général chez Actimis Pharmaceuticals, Inc.

Profil

Peter C.
M.
McWilliams currently works at Actimis Pharmaceuticals, Inc., as Chairman & Chief Executive Officer, Liphorus Pharmaceuticals, Inc., as Chairman & Chief Executive Officer, Artielle ImmunoTherapeutics, Inc., as Director, Harkness Pharmaceuticals, Inc., as Director & Director-Business Development, Sanderling Management CO LLC, as venture Partner from 2010, and Glycomine, Inc., as Chief Business Officer.
Dr. McWilliams also formerly worked at Axikin Pharmaceuticals, Inc., as Chairman & Acting Chief Executive Officer, CalciMedica Subsidiary, Inc., as Co-Chairman, Trinity Biosystems, Inc., as Chairman, Genentech, Inc., as Product Manager from 1996 to 1999, Cylene Pharmaceuticals, Inc., as Principal, Oxford Molecular Group Plc, as Principal, Booz Allen Hamilton, Inc., as Associate from 1994 to 1996, and Kingsbury Capital Partners LP, as Principal.
Dr. McWilliams received his undergraduate degree in 1987 from the University of Cambridge, doctorate degree in 1991 from Princeton University, graduate degree in 1990 from Princeton University, and Masters Business Admin degree in 1996 from Columbia Business School.

Postes actifs de Peter C. M. McWilliams

Sociétés	Poste	Début
Sanderling Management CO LLC	Private Equity Investor	01/01/2000
Actimis Pharmaceuticals, Inc.	Directeur Général	-
Harkness Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Artielle ImmunoTherapeutics, Inc.	Directeur/Membre du Conseil	-
Liphorus Pharmaceuticals, Inc.	Directeur Général	-
Glycomine, Inc.	Corporate Officer/Principal	-

Anciens postes connus de Peter C. M. McWilliams

Sociétés	Poste	Fin
Genentech, Inc.	Corporate Officer/Principal	31/12/1999
Booz Allen Hamilton, Inc.	Corporate Officer/Principal	01/01/1996
Oxford Molecular Group Plc	Corporate Officer/Principal	-
░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-